Cargando…
Skin-Derived ABCB5(+) Mesenchymal Stem Cells for High-Medical-Need Inflammatory Diseases: From Discovery to Entering Clinical Routine
The ATP-binding cassette superfamily member ABCB5 identifies a subset of skin-resident mesenchymal stem cells (MSCs) that exhibit potent immunomodulatory and wound healing-promoting capacities along with superior homing ability. The ABCB5(+) MSCs can be easily accessed from discarded skin samples, e...
Autores principales: | Niebergall-Roth, Elke, Frank, Natasha Y., Ganss, Christoph, Frank, Markus H., Kluth, Mark A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820160/ https://www.ncbi.nlm.nih.gov/pubmed/36613507 http://dx.doi.org/10.3390/ijms24010066 |
Ejemplares similares
-
Kinetics of Wound Development and Healing Suggests a Skin-Stabilizing Effect of Allogeneic ABCB5(+) Mesenchymal Stromal Cell Treatment in Recessive Dystrophic Epidermolysis Bullosa
por: Niebergall-Roth, Elke, et al.
Publicado: (2023) -
Corrigendum to ABCB5+ mesenchymal stromal cells facilitate complete
and durable wound closure in recessive dystrophic epidermolysis bullosa
[Cytotherapy 25 (2023) 782–788/1562]
por: Dieter, Kathrin, et al.
Publicado: (2023) -
In vivo safety profile and biodistribution of GMP-manufactured human skin-derived ABCB5-positive mesenchymal stromal cells for use in clinical trials
por: TAPPENBECK, NILS, et al.
Publicado: (2019) -
Process data of allogeneic ex vivo-expanded ABCB5(+) mesenchymal stromal cells for human use: off-the-shelf GMP-manufactured donor-independent ATMP
por: Ballikaya, Seda, et al.
Publicado: (2020) -
Clinical trial of ABCB5(+) mesenchymal stem cells for recessive dystrophic epidermolysis bullosa
por: Kiritsi, Dimitra, et al.
Publicado: (2021)